ecancer

New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK

11 Jun 2010

Adaptive design for clinical trials

Dr Donald Berry - M.D. Anderson Cancer Center, University of Texas, USA

25 May 2010

Preventive treatment for breast cancer

Dr Judy Garber - Dana Farber Cancer Institute, Boston, USA

25 May 2010

Ways to predict efficacy of anthracyclines

Dr Christine Desmedt - Jules Bordet Institute, Brussels

22 Apr 2010

Advances in breast cancer treatments

Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK

22 Apr 2010

Targeted therapy for breast cancer

Dr Alison Jones - Dept of Medical Oncology, Royal Free Hospital, London

22 Apr 2010

Progress made at the Christie Cancer Centre and possibilities for the future

Dr Andrew Baildam - The Christie Cancer Centre and The University Hospital, Manchester, UK

22 Apr 2010

Prevention of breast cancer

Prof Carlo La Vecchia - University of Milan and Mario Negri Institute for Pharmacological Research, Italy

22 Apr 2010

Barriers for patient participation in clinical trials

Ingrid Kossler - Swedish Breast Cancer Association

22 Apr 2010

Issues and techniques relating to lymph nodes

Dr Michael Douek - Guy's and St Thomas' Hospitals, London

22 Apr 2010

Implementation of a national breast service

Prof Niall O'Higgins - Royal College of Surgeons in Ireland, Bahrain

22 Apr 2010

Management of symptoms in women with breast cancer

Dr Patricia Ganz - School of Public Health and the David Geffen School of Medicine, UCLA, Los Angeles

22 Apr 2010

More from ecancer